India’s Own Covid-19 Vaccine is 81 Percent Effective

Yesterday, Hyderabad-based Bharat Biotech published interim results from the Phase 3 trial of it Covid-19 vaccine, branded as Covaxin.  25,8000 subjects participated in the trial. The trial found 43 cases of COVID-19 patients who showed symptoms ranging from mild to moderate and severe, and of the total cases, 36 were from...

Philips Offers Mobile ICU Units For Covid-19 in India

Designed to meet the critical-care requirements of  Covid-19 patients, the Philips  pre-fabricated Intensive Care Unit (ICU) has a capacity for nine beds and is locally manufactured by Philips in India. Each ICU unit can be assembled in one day at the chosen site. Each of these portable ICUs comes equipped...

Serum Institute Preps for Phase 3 Trial of Covid Vaccine

Five sites across India are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology  Secretary Renu Swarup said on Monday. The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries